Global Epidemiology of Lung Cancer

While lung cancer has been the leading cause of cancer-related deaths for many years in the United States, incidence and mortality statistics – among other measures – vary widely worldwide. The aim of this study was to review the evidence on lung cancer epidemiology, including data of international...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Julie A. Barta, Charles A. Powell, Juan P. Wisnivesky
Formato:	article
Lenguaje:	EN
Publicado:	Ubiquity Press 2019
Materias:	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/4ae20ff1433848d5b7c6418b963f54bc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4ae20ff1433848d5b7c6418b963f54bc
record_format	dspace
spelling	oai:doaj.org-article:4ae20ff1433848d5b7c6418b963f54bc2021-12-02T07:18:52ZGlobal Epidemiology of Lung Cancer2214-999610.5334/aogh.2419https://doaj.org/article/4ae20ff1433848d5b7c6418b963f54bc2019-01-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2419https://doaj.org/toc/2214-9996While lung cancer has been the leading cause of cancer-related deaths for many years in the United States, incidence and mortality statistics – among other measures – vary widely worldwide. The aim of this study was to review the evidence on lung cancer epidemiology, including data of international scope with comparisons of economically, socially, and biologically different patient groups. In industrialized nations, evolving social and cultural smoking patterns have led to rising or plateauing rates of lung cancer in women, lagging the long-declining smoking and cancer incidence rates in men. In contrast, emerging economies vary widely in smoking practices and cancer incidence but commonly also harbor risks from environmental exposures, particularly widespread air pollution. Recent research has also revealed clinical, radiologic, and pathologic correlates, leading to greater knowledge in molecular profiling and targeted therapeutics, as well as an emphasis on the rising incidence of adenocarcinoma histology. Furthermore, emergent evidence about the benefits of lung cancer screening has led to efforts to identify high-risk smokers and development of prediction tools. This review also includes a discussion on the epidemiologic characteristics of special groups including women and nonsmokers. Varying trends in smoking largely dictate international patterns in lung cancer incidence and mortality. With declining smoking rates in developed countries and knowledge gains made through molecular profiling of tumors, the emergence of new risk factors and disease features will lead to changes in the landscape of lung cancer epidemiology.Julie A. BartaCharles A. PowellJuan P. WisniveskyUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 85, Iss 1 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
spellingShingle	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 Julie A. Barta Charles A. Powell Juan P. Wisnivesky Global Epidemiology of Lung Cancer
description	While lung cancer has been the leading cause of cancer-related deaths for many years in the United States, incidence and mortality statistics – among other measures – vary widely worldwide. The aim of this study was to review the evidence on lung cancer epidemiology, including data of international scope with comparisons of economically, socially, and biologically different patient groups. In industrialized nations, evolving social and cultural smoking patterns have led to rising or plateauing rates of lung cancer in women, lagging the long-declining smoking and cancer incidence rates in men. In contrast, emerging economies vary widely in smoking practices and cancer incidence but commonly also harbor risks from environmental exposures, particularly widespread air pollution. Recent research has also revealed clinical, radiologic, and pathologic correlates, leading to greater knowledge in molecular profiling and targeted therapeutics, as well as an emphasis on the rising incidence of adenocarcinoma histology. Furthermore, emergent evidence about the benefits of lung cancer screening has led to efforts to identify high-risk smokers and development of prediction tools. This review also includes a discussion on the epidemiologic characteristics of special groups including women and nonsmokers. Varying trends in smoking largely dictate international patterns in lung cancer incidence and mortality. With declining smoking rates in developed countries and knowledge gains made through molecular profiling of tumors, the emergence of new risk factors and disease features will lead to changes in the landscape of lung cancer epidemiology.
format	article
author	Julie A. Barta Charles A. Powell Juan P. Wisnivesky
author_facet	Julie A. Barta Charles A. Powell Juan P. Wisnivesky
author_sort	Julie A. Barta
title	Global Epidemiology of Lung Cancer
title_short	Global Epidemiology of Lung Cancer
title_full	Global Epidemiology of Lung Cancer
title_fullStr	Global Epidemiology of Lung Cancer
title_full_unstemmed	Global Epidemiology of Lung Cancer
title_sort	global epidemiology of lung cancer
publisher	Ubiquity Press
publishDate	2019
url	https://doaj.org/article/4ae20ff1433848d5b7c6418b963f54bc
work_keys_str_mv	AT julieabarta globalepidemiologyoflungcancer AT charlesapowell globalepidemiologyoflungcancer AT juanpwisnivesky globalepidemiologyoflungcancer
_version_	1718399514371424256

Global Epidemiology of Lung Cancer

Ejemplares similares